Enersense's wind power development portfolio has been divested, and losses from non-core operations ...
Redeye comments on Surgical Science announcing an opportunistic bolt-on deal by offering to acquire ...
AcuCort (”AcuCort” eller ”Bolaget”) meddelade den 19 december år 2024 att Bolaget har lämnat in en I...
Förra veckan aviserade kontraktstillverkaren Hanza förvärvet av finska Leden Group, en ledande kontr...
New defence order from BAE Systems worth SEK 53m Additional order from Denmark also expected near-te...
Mendus has reported positive top-line data for its Phase I ALISON trial, which is evaluating lead of...
Redeye comments on a new additional supplier of Terbinafine that already holds an EU certificate of ...
Redeye leaves a comment following Lipum’s announcement of a grant from Eurostars.
On December 17th, STENOCARE announced that the company has received approval for a new product in De...
Alisa Bank issued a profit warning for 2024, lowering expectations for total income and profitabilit...
Redeye initiates coverage of Safello, a Swedish cryptocurrency brokerage founded in 2013 that has ce...
Redeye is positive to the news regarding the support from a new law in New York state for insurance ...
Surprising Q4 PW and CEO resignation, but likely two isolated events Volatile systems business behin...
Redeye comments on Lipigon's change of CEOs.
Redeye sees encouraging news from Dignitana supporting insurance coverage from private health insure...
